An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++

An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++

Abstract The ongoing transmission of Mycobacterium (M.) leprae reflected in a very slow decline in leprosy incidence, forces us to be innovative and conduct cutting-edge research. Single dose rifampicin (SDR) as post-exposure prophylaxis (PEP) for contacts of leprosy patients, reduces their risk to...

Full description

Bibliographic Details
Main Authors: Liesbeth F Mieras, Anna T Taal, Wim H van Brakel, Emmanuelle Cambau, Paul R Saunderson, W Cairns S Smith, Cita Rosita S Prakoeswa, Linda Astari, David M Scollard, Dejair Caitano do Nascimento, Jacques Grosset, Hemanta K Kar, Shinzo Izumi, Laura Gillini, Marcos C L Virmond, Marieke G G Sturkenboom
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Infectious Diseases
Subjects:
Post-exposure prophylaxis
Chemoprophylaxis
Intervention study
Leprosy
Rifampicin
Moxifloxacin
Online Access:http://link.springer.com/article/10.1186/s12879-018-3402-4

Internet

http://link.springer.com/article/10.1186/s12879-018-3402-4

Similar Items